Lockdown effects on drug users, services and supply
28.04.2020 - Qualitative monitoring through the feedback from the TREND scheme and network.
Read more
Tobacco smoking and cessation
20.04.2020 - The 2019 overview of the OFDT "tobacco review" is now available in English.
Read more
Vienna 2019: the CND under stress
14.04.2020 - An analysis of the 62nd regular session of the Commission on Narcotic Drugs (CND).
Read moreLatest news from the EMCDDA
EU Drug Markets Report 2019
26.11.2019 - Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today.
The EMCDDA and Europol launch the 2019 EU Drug Markets Report. This 250-page graphic-rich report will be accompanied by 12 supporting papers.
COVID-19 – Drug supply via darknet markets
05.05.2020 - This EMCDDA report is a rapid and preliminary analysis of the impact of COVID-19 on selected online markets..
COVID-19 and people who use drugs
25.03.2020 - Up-to-date information can be found in the guidelines prepared by national public health sources and the regular updates from the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO).
Quick access to the EMCDDA main publications archives
Databases
The OFDT provides an online bibliographic database on addiction.
The EMCDDA provides a database on their publications of interest.
Drugs in Europe
2019 EMCDDA European Drug Report
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
